Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-24 @ 11:45 PM
NCT ID:
NCT03106051
Eligibility Criteria:
Inclusion Criteria:
* The decision to treat with Otezla® has been made independently before inclusion in this study
* Patient age ≥ 18 years
* Existing diagnosis of active psoriatic arthritis
* At least moderately severe psoriatic arthritis (Physician's Global Assessment (PGA) scale ≥ 2)
* Insufficient response or intolerance to previous Disease-Modifying Anti-Rheumatic Drug (DMARD) treatment (disease modifying anti-rheumatic drugs)
* A written informed consent statement by the patient permitting data collection, evaluation, storage and transfer
Exclusion Criteria:
* Pregnancy
* Hypersensitivity to apremilast or one of the other ingredients in the film tablets
* Other criteria according to the summary of product characteristics Breast-feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03106051
Study Brief:
Protocol Section:
NCT03106051